Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 53INDUSTRY 12NIH 3OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Sarcoma 1Nasopharyngeal Carcinoma 1Lymphoma, Extranodal NK-T-Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3nimotuzumab 1anlotinib 1Radiotherapy, Intensity-Modulated 1Gemcitabine 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Nasopharyngeal Carcinoma × Gemcitabine × Clear all
NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

ChineseAMS

Phase 1/2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡